Paper4584686
Bacteriophage receptors.
Lindberg AA. Annu Rev Microbiol, 1973. Cited by 302 papers, by iCite.
11 sourcespapers-2026-11-12-0.1.0
Cite this record
ConductScience Library. Bacteriophage receptors. Papers, record 4584686. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/4584686
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics13
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Bacteria | Major topic |
| Bacteriophages | Major topic |
| Receptors, Drug | Major topic |
| Bacterial Proteins | |
| Binding Sites | |
| Cell Membrane | |
| Flagella | |
| Lipopolysaccharides | |
| Lysogeny | |
| Peptidoglycan | |
| Polysaccharides, Bacterial | |
| Species Specificity | |
| Teichoic Acids |
Source PubMed
Cited by145
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 302 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 40,872,508 | Bacteriophage Therapy: Discovery, Development, and FDA Approval Pathways. | Pharmaceuticals (Basel) | 2025 | https://conductscience.org/library/papers/40872508 | PubMed |
| 40,846,711 | Anti-restriction functions of injected phage proteins revealed by peeling back layers of bacterial immunity. | Nat Commun | 2025 | https://conductscience.org/library/papers/40846711 | PubMed |
| 40,833,425 | Bacteriophage resistance evolution in a honey bee pathogen. | Microbiology (Reading) | 2025 | https://conductscience.org/library/papers/40833425 | PubMed |
| 39,599,390 | Strain-Specific Infection of Phage AP1 to Rice Bacterial Brown Stripe Pathogen Acidovorax oryzae. | Plants (Basel) | 2024 | https://conductscience.org/library/papers/39599390 | PubMed |
| 39,315,775 | Only time will tell: lipopolysaccharide glycoform and biofilm-formation kinetics in Salmonella species and Escherichia coli. | J Bacteriol | 2024 | https://conductscience.org/library/papers/39315775 | PubMed |
| 38,863,081 | Isolation and characterization of a phage collection against Pseudomonas putida. | Environ Microbiol | 2024 | https://conductscience.org/library/papers/38863081 | PubMed |
| 37,420,021 | Phylogenomics of the Liquorilactobacillus Genus. | Curr Microbiol | 2023 | https://conductscience.org/library/papers/37420021 | PubMed |
| 35,632,829 | Resistance of Xanthomonas oryzae pv. oryzae to Lytic Phage X2 by Spontaneous Mutation of Lipopolysaccharide Synthesis-Related Glycosyltransferase. | Viruses | 2022 | https://conductscience.org/library/papers/35632829 | PubMed |
| 35,620,963 | Biological foundations of successful bacteriophage therapy. | EMBO Mol Med | 2022 | https://conductscience.org/library/papers/35620963 | PubMed |
| 34,878,184 | Bacteria elicit a phage tolerance response subsequent to infection of their neighbors. | EMBO J | 2022 | https://conductscience.org/library/papers/34878184 | PubMed |
| 34,782,783 | Bacteriophages and their potential for treatment of gastrointestinal diseases. | Nat Rev Gastroenterol Hepatol | 2022 | https://conductscience.org/library/papers/34782783 | PubMed |
| 34,465,216 | Cell wall deficiency as an escape mechanism from phage infection. | Open Biol | 2021 | https://conductscience.org/library/papers/34465216 | PubMed |
| 34,437,908 | Intestinal virome and therapeutic potential of bacteriophages in liver disease. | J Hepatol | 2021 | https://conductscience.org/library/papers/34437908 | PubMed |
| 34,372,537 | Advances in Phage Therapy: Targeting the Burkholderia cepacia Complex. | Viruses | 2021 | https://conductscience.org/library/papers/34372537 | PubMed |
| 34,262,535 | Differential Bacteriophage Efficacy in Controlling Salmonella in Cattle Hide and Soil Models. | Front Microbiol | 2021 | https://conductscience.org/library/papers/34262535 | PubMed |
| 34,209,785 | Identification of Receptor Binding Proteins in Flagellotropic Agrobacterium Phage 7-7-1. | Viruses | 2021 | https://conductscience.org/library/papers/34209785 | PubMed |
| 33,784,980 | Diversity and characterization of temperate bacteriophages induced in Pasteurella multocida from different host species. | BMC Microbiol | 2021 | https://conductscience.org/library/papers/33784980 | PubMed |
| 33,670,836 | The Age of Phage: Friend or Foe in the New Dawn of Therapeutic and Biocontrol Applications? | Pharmaceuticals (Basel) | 2021 | https://conductscience.org/library/papers/33670836 | PubMed |
| 33,394,168 | Characterization of bacteriophage T7-Ah reveals its lytic activity against a subset of both mesophilic and psychrophilic Aeromonas salmonicida strains. | Arch Virol | 2021 | https://conductscience.org/library/papers/33394168 | PubMed |
| 33,048,924 | High-throughput mapping of the phage resistance landscape in E. coli. | PLoS Biol | 2020 | https://conductscience.org/library/papers/33048924 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- References
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/4584686
GET https://conductscience.org/api/papers/v1/4584686/cited_by?page=2